RecruitingNot ApplicableNCT05661448

Promoting Cognitive Health in Schizophrenia

Promoting Cognitive Health in Schizophrenia: A National Collaborative Effort to Implement Online Psychological Interventions


Sponsor

Douglas Mental Health University Institute

Enrollment

390 participants

Start Date

Apr 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to effectively implement virtually-delivered interventions in mental health institutions nationwide to improve the cognitive health of individuals living with schizophrenia. The main objectives are: * To determine the clinical effectiveness of two virtual cognitive health interventions (i.e., Action-Based Cognitive Remediation or MetaCognitive Training). * To evaluate our implementation strategy involving the virtual delivery of cognitive health interventions combined with a digital learning platform to train mental health practitioners. Participants will be assessed for the severity of symptoms, cognitive performance, and overall functioning before and after receiving the intervention. Qualitative interviews will also be conducted with participants and therapists to evaluate the implementation strategies.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests an online group program designed to improve thinking skills (memory, attention, problem-solving) in people living with schizophrenia or related psychotic disorders. The program is delivered remotely, making it accessible without needing to travel to a clinic. **You may be eligible if...** - You have been diagnosed with schizophrenia, schizoaffective disorder, or a related psychotic disorder - You are receiving treatment through one of the participating mental health services - Your symptoms are currently stable, as judged by your treating clinician - You have access to a private space where you can attend online group sessions - You are able to nominate an emergency contact - You can read and communicate in English or French **You may NOT be eligible if...** - You have an intellectual disability - You are currently hospitalized - You are assessed as high suicide risk Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCognitive remediation

The goal of this program is to improve performance on cognitive domains known to hinder functioning. It aims to promote positive attitudes towards learning and facilitate the development of independent learning skills to foster competence and confidence. Another aim is to increase patients' awareness of their cognitive strengths and weaknesses and their own problem solving strategies.

BEHAVIORALMetaCognitive Training

The metacognitive training (MCT) program is based on the theoretical foundations of cognitive models of schizophrenia but employs a slightly different focus in its therapeutic approach targeting the specific cognitive biases underlying delusions. The modules aim to raise awareness of these biases and prompts participants to critically reflect on and update their problem-solving repertoire.


Locations(5)

Faculty of Medicine, University of British Columbia

Vancouver, British Columbia, Canada

Kingston Health Sciences Centre, Queen's University

Kingston, Ontario, Canada

Institute of Mental Health Research, University of Ottawa

Ottawa, Ontario, Canada

Ontario Shoares Centre for Mental Health Sciences, University of Toronto

Toronto, Ontario, Canada

Douglas Mental Health University Institute

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05661448


Related Trials